Whipple disease mimicking polymyalgia rheumatica with initial response to tocilizumab

Intern Med J. 2021 Dec;51(12):2151-2152. doi: 10.1111/imj.15281.

Authors

Loic Meudec^{1

2}, Germain Jelin^{1

2}, Julia Goossens^{1

2}, Marine Forien^{1

2}, Hervé Jacquier^{1

3}, Philippe Dieudé^{1

2}, Sébastien Ottaviani^{1

2}

Affiliations

¹ Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France.
² AP-HP, Service de Rhumatologie, Hôpital Bichat, Paris, France.
³ AP-HP, Service de Bactériologie-Virologie, Hôpital Lariboisière, Paris, France.

PMID: 34939291
DOI: 10.1111/imj.15281

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Diagnosis, Differential
Giant Cell Arteritis* / diagnosis
Humans
Polymyalgia Rheumatica* / diagnosis
Polymyalgia Rheumatica* / drug therapy
Whipple Disease* / diagnosis
Whipple Disease* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
tocilizumab